Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Molecular & Cellular Proteomics : MCP|June 27, 2013
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissuesHari Kosanam, Ioannis Prassas, Caitlin C Chrystoja, et al.
Journal of Immunology Research|June 1, 2018
High-Density Lipoprotein Reduction Differentially Modulates to Classical and Nonclassical Monocyte Subpopulations in Metabolic Syndrome Patients and in LPS-Stimulated Primary Human Monocytes In VitroJohanna L Grün, Aaron N Manjarrez-Reyna, Angélica Y Gómez-Arauz, et al.
Plos One|September 3, 2010
Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysisFelix Rückert, Gihan Dawelbait, Christof Winter, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 9, 2019
Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinomaLouisa Bolm, Ekaterina Petrova, Jürgen Weitz, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 19, 2020
Adipose-Derived Biogenic Nanoparticles for Suppression of InflammationMing Tian, Taylor Ticer, Qikun Wang, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 17, 2019
Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer CellsUghur Aghamaliyev, Haristi Gaitantzi, Maria Thomas, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 29, 2020
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort studyLouisa Bolm, Kristina Ohrner, Gennaro Nappo, et al.
Oncotarget|July 13, 2014
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabineOrkhan Isayev, Vanessa Rausch, Nathalie Bauer, et al.
Cell Reports. Medicine|June 3, 2026
Targeted extracellular vesicle-photoimmunotherapy remodels stromal-immune microenvironment to boost chemo-immunotherapy in preclinical modelsChengming Qu, Jie Liu, Jinpeng Cen, et al.
Oncotarget|January 7, 2017
Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinomaShakhawan Mustafa, Longqiang Pan, Aseel Marzoq, et al.
Pageof 8